Abu Dhabi: All Tylenol containers found to be in breach of the technical specifications of both public and private hospitals and pharmacies in the UAE have been removed from the market.
Dr Ameen Hussain Al Amiri, Executive Director for Medical Practices and Licence at the Ministry of Health, assured the public that all forms of the medicine currently on the market were safe.
The UAE's Minister of Health received a notification from the pharmaceutical company which produces Tylenol to the effect that it would pull out some containers because of complications that had occurred in three countries.
The Ministry of Health lauded the efforts of the pharmaceutical company and its local agent for their swift reaction and responsible stance in alerting authorities about the defect as soon as it was discovered it. It said such action was expected from all the MoH's strategic partners inside the UAE and abroad.
The Ministry of Health also lauded the quick response of all parties related in retrieving the medicine and said such actions reflected the high sense of responsibility shown by everyone involved.
Meanwhile, the Ministry of Health announced that all the data and information related to Sibutramine — weight-loss medication known by its commercial name, Reductil — had shown that the drug was safe.
The ministry recommended that the medicine should not pulled out from the market, after taking into consideration warnings issued by the US Food and Drug Administration (FDA) concerning the use of this drug by heart patients.